Skip to main content
OpenTrials
Completed

NCT Number: NCT04479280

Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.

Novel coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this pneumonia was first emerged in December 2019 in Wuhan, China and rapidly spread around the world .

Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coagulation Disorder Cardiovascular Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Assiut university

Asyut, 71111, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COVID 19 critically ill patients

Exclusion criteria

  • any critical illness not related to COVID 19

Treatment and study plan

Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA

Device

studying coagulation disorders in COVID19 critically ill patients

Primary outcomes

  1. clot rate formation

    Time frame: 30 minutes

    measuring how rapid the sample will get clotted

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Evaluation of the Role of Sonoclot Signature in Assessment of Coagulopathy in Critically Ill COVID 19 Patients

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 21, 2020
Registry last updated
Sep 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.